SavedAdd your journal

Journals / İzmir Eğitim ve Araştırma Hastanesi Tıp Dergisi / 2021 / Cilt: 25 - Sayı: 3

COMPARISON OF FETUIN A LEVELS BEFORE AND AFTER IMMUNOTHERAPY IN PATIENTS WITH ALLERGIC RHINITIS

ALLERJİK RİNİTLİ HASTALARDA İMMÜNOTERAPİ ÖNCESİ VE SONRASI FETUİN A DÜZEYLERİNİN KARŞILAŞTIRILMASI

Ece ONUR
Ferda BİLGİR
Papatya DEGİRMENCİ
Cengiz KİRMAZ
Pages
1–9
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The decrease in serum fetuin A (P=0.046) and nasal Fetuin A (P

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Role of Fetuin-A, a serum glycoprotein, in various diseases has been reported in different studies.
📊
Key Findings & Data:Material and Methods: 30 patients aged over 18 and 30 healthy volunteers due to AR were enrolled in the study.
💡
Conclusion & Impact:The decrease in serum fetuin A (P=0.046) and nasal Fetuin A (P
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: Role of Fetuin-A, a serum glycoprotein, in various diseases has been reported in different studies. There is no available study yet about Fetuin A in allergic diseases. We aimed to determine the role of Fetuin-A in Allergic Rhinitis (AR). Material and Methods: 30 patients aged over 18 and 30 healthy volunteers due to AR were enrolled in the study. Initial and sixth month serum level and nasal lavage Fetuin-A levels as well as nasal symptom scores were compared. Results: Mean Serum Fetuin-A level of patients with AR was found to be 1010.44 ± 679.84mg/L, while mean nasal Fetuin A level was found 946.52 ± 127.123mg/L. The decrease in serum fetuin A (P=0.046) and nasal Fetuin A (P

Özet

Giriş: Bir serum glikoproteini olan Fetuin-A'nın çeşitli hastalıklardaki rolü farklı çalışmalarda bildirilmiştir. Alerjik hastalıklarda Fetuin A ile ilgili henüz bir çalışma yoktur. Allerjik Rinitte (AR) Fetuin-A'nın rolünü belirlemeyi amaçladık. Gereç ve Yöntemler: Allerjik Riniti olan 18 yaş üstü 30 hasta ve 30 sağlıklı gönüllü çalışmaya alındı. Başlangıç ve altıncı ay serum ve nazal lavaj Fetuin-A düzeyleri ile nazal semptom skorları karşılaştırıldı. Bulgular: AR'li hastaların ortalama Serum Fetuin-A düzeyi 1010.44 ± 679.84mg / L, ortalama nazal Fetuin A düzeyi 946.52 ± 127.123mg / L olarak bulundu. Tedavi sonrası karşılaşılan serum fetuin A (P = 0.046) ve nazal Fetuin A (P

🔖

Cite This Article

ONUR, E., BİLGİR, F., DEGİRMENCİ, P., KİRMAZ, C. (2022). COMPARISON OF FETUIN A LEVELS BEFORE AND AFTER IMMUNOTHERAPY IN PATIENTS WITH ALLERGIC RHINITIS. İzmir Eğitim ve Araştırma Hastanesi Tıp Dergisi, Cilt: 25 - Sayı: 3, 1–9. https://ajindex.com/articles/557754

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Brożek JL, Bousquet J, Agache I, Agarwal A, BachertC, Bosnic-Anticevich S et al. Allergic rhinitis and its impact on asthma (ARIA) guidelines-2016 Revision J Allergy Clin Immunol 2016; 140 (4); 950-8
  2. Scadding GK, Kariyawasam HH, Scadding G, Mirakian R, Buckley RJ, Dixon T et al. BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis. Clin Exp Allergy 2017; 47(7): 856–89
  3. Munoz-Cano R, Ribo P, Araujo G, Giralt E, Sanchez-Lopez J, Valero A.Severity of allergic rhinitis impacts sleep and anxiety: results from a large Spanish cohort. Clin Transl Allergy 2018; 8(1): 23
  4. Meltzer EO, Bukstein DA. The economic impact of allergic rhinitis and current guidelines for treatment. Ann Allergy Asthma Immunol 2011; 106(Suppl 2): S12-S6
  5. Schmitt J, Schwarz K, Stadler E, Wustenberg EG. Allergy immunotherapy for allergic rhinitis effectively prevents asthma: Results from a large retrospective cohort study. J Allergy Clin Immunol 2015; 136(6): 1511-6
  6. Diamant Z, Boot JD, Mantzouranis E, Flohr R, Sterk PJ, Gerth van Wijk R. Biyomarkers in asthma and allergic rhinitis. Pulm Pharmacol Ther 2010; 23(6): 468-81
  7. Belkowski SM, Boot JD, Mascelli MA, Diamant Z, de Garavilla L, Hertzog B et al. Cleaved secretory leucocyte protease inhibitör as a biomarker of chymase activity in allergic airway disease. Clin Exp Allergy 2009; 39(8): 1179-86
  8. Shamji MH, Durham SR. Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers. J Allergy Clin Immunol 2017; 140(6): 1485–98
  9. Golden PM, Gleason MM, Togias A. Cysteinil leukotrienes: multifunctional mediators in allergic rhinitis. Clin and Exp Allergy 2006; 36(6): 689-703
  10. Lebreton JP, Joisel F, Raoult JP, Lannuzel B, Rogez JP, Humbert G. Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant. J Clin Invest 1979; 64(4): 1118-29
  11. Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, Böhm R et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 2003; 361(9360): 827-33
  12. Jersman HP, Dransfield I, Hart SP. Fetuin/alpha2-HS glycoprotein enhances phagocytosis of apoptotic cells and macropinocytosis by human macrophages. Clin Sci 2003; 105(3): 273-8
  13. Ciprandi G, Passalacque G. Allergy and the nose. Clin Exp Immunol 2008; 153 (Suppl 1): 22-6